Primate Retinal Signaling Pathways: Suppressing ON-Pathway Activity in Monkey With Glutamate Analogues Mimics Human CSNB1-NYX Genetic Night Blindness
1 Department of Ophthalmology and Visual Sciences, W. K. Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan; and 2 National Institute of Deafness and Communicative Disorders and 3 National Eye Institute, National Institutes of Health, Bethesda, Maryland Submitted 9 April 2004; accepted...
Saved in:
Published in | Journal of neurophysiology Vol. 93; no. 1; pp. 481 - 492 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Am Phys Soc
01.01.2005
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | 1 Department of Ophthalmology and Visual Sciences, W. K. Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan; and 2 National Institute of Deafness and Communicative Disorders and 3 National Eye Institute, National Institutes of Health, Bethesda, Maryland
Submitted 9 April 2004;
accepted in final form 19 August 2004
Retinal ON -pathway dysfunction is implicated in human complete-type congenital stationary night blindness (CSNB1), a Mendelian genetic condition that results from mutations in the NYX gene encoding the protein nyctalopin. We probed cone pathway dysfunction in four human genotyped CSNB1 affected males by electroretinogram (ERG) recordings elicited with photopic sinusoidal and rapid- ON / OFF -ramp flicker stimuli that are reputed to elicit ON / OFF -pathway activity selectively. Results were analyzed in relation to ERG abnormalities created in anesthetized non-human primates by intravitreal application of glutamate analogues that selectively suppress retinal ON - or OFF -pathway bipolar cell activity. 2-amino-4-phosphonobutyric acid (APB), which selectively blocks light responses of ON -pathway depolarizing bipolar cells, fully recreated the essential ERG abnormalities found for human CSNB1 under the condition that the OFF -pathway remained active. Both CSNB1- NYX humans and APB-treated monkey retina lacked the normal amplitude dip and the phase deflection that occurs in the fundamental component near 12 Hz for sinusoidal flicker stimuli. The OFF -pathway suppressing agent, cis -2,3-piperidine-dicarboxylic acid (PDA), gave results in monkey quite discordant to CSNB1 human for sinusoidal stimulation. The results implicated a specific ON -pathway signaling deficiency in CSNB1- NYX males with no evidence of OFF -pathway involvement. Likewise, rapid- ON / OFF ramping stimuli also indicated that the functional deficit was localized to the ON pathway. Analysis of non-human primate retinal responses after drug application demonstrated a complexity to ON / OFF -pathway contributions to ramping ON / OFF ERG responses not previously anticipated. These results support the hypothesis that nyctalopin acts principally or exclusively within the ON pathway at the level of depolarizing bipolar cells, and thus human CSNB1- NYX subjects provide an opportunity to probe the primate visual system for consequences of ON -pathway deficits.
Address for reprint requests and other correspondence: Correspondence : Paul Sieving, MD, Ph.D., National Eye Institute, Bldg 31 Room 6A03,31 Center Drive, MSC 2510, Bethesda, MD 20892-2110, Phone: 301-496-2234, Fax: 301-496-9970, Email: paulsieving{at}nei.nih.gov |
---|---|
AbstractList | Retinal on-pathway dysfunction is implicated in human complete-type congenital stationary night blindness (CSNB1), a Mendelian genetic condition that results from mutations in the NYX gene encoding the protein nyctalopin. We probed cone pathway dysfunction in four human genotyped CSNB1 affected males by electroretinogram (ERG) recordings elicited with photopic sinusoidal and rapid-on/off-ramp flicker stimuli that are reputed to elicit on/off-pathway activity selectively. Results were analyzed in relation to ERG abnormalities created in anesthetized non-human primates by intravitreal application of glutamate analogues that selectively suppress retinal on- or off-pathway bipolar cell activity. 2-amino-4-phosphonobutyric acid (APB), which selectively blocks light responses of on-pathway depolarizing bipolar cells, fully recreated the essential ERG abnormalities found for human CSNB1 under the condition that the off-pathway remained active. Both CSNB1- NYX humans and APB-treated monkey retina lacked the normal amplitude dip and the phase deflection that occurs in the fundamental component near 12 Hz for sinusoidal flicker stimuli. The off-pathway suppressing agent, cis-2,3-piperidine-dicarboxylic acid (PDA), gave results in monkey quite discordant to CSNB1 human for sinusoidal stimulation. The results implicated a specific on-pathway signaling deficiency in CSNB1- NYX males with no evidence of off-pathway involvement. Likewise, rapid-on/off ramping stimuli also indicated that the functional deficit was localized to the on pathway. Analysis of non-human primate retinal responses after drug application demonstrated a complexity to on/off-pathway contributions to ramping on/off ERG responses not previously anticipated. These results support the hypothesis that nyctalopin acts principally or exclusively within the on pathway at the level of depolarizing bipolar cells, and thus human CSNB1- NYX subjects provide an opportunity to probe the primate visual system for consequences of on-pathway deficits. 1 Department of Ophthalmology and Visual Sciences, W. K. Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan; and 2 National Institute of Deafness and Communicative Disorders and 3 National Eye Institute, National Institutes of Health, Bethesda, Maryland Submitted 9 April 2004; accepted in final form 19 August 2004 Retinal ON -pathway dysfunction is implicated in human complete-type congenital stationary night blindness (CSNB1), a Mendelian genetic condition that results from mutations in the NYX gene encoding the protein nyctalopin. We probed cone pathway dysfunction in four human genotyped CSNB1 affected males by electroretinogram (ERG) recordings elicited with photopic sinusoidal and rapid- ON / OFF -ramp flicker stimuli that are reputed to elicit ON / OFF -pathway activity selectively. Results were analyzed in relation to ERG abnormalities created in anesthetized non-human primates by intravitreal application of glutamate analogues that selectively suppress retinal ON - or OFF -pathway bipolar cell activity. 2-amino-4-phosphonobutyric acid (APB), which selectively blocks light responses of ON -pathway depolarizing bipolar cells, fully recreated the essential ERG abnormalities found for human CSNB1 under the condition that the OFF -pathway remained active. Both CSNB1- NYX humans and APB-treated monkey retina lacked the normal amplitude dip and the phase deflection that occurs in the fundamental component near 12 Hz for sinusoidal flicker stimuli. The OFF -pathway suppressing agent, cis -2,3-piperidine-dicarboxylic acid (PDA), gave results in monkey quite discordant to CSNB1 human for sinusoidal stimulation. The results implicated a specific ON -pathway signaling deficiency in CSNB1- NYX males with no evidence of OFF -pathway involvement. Likewise, rapid- ON / OFF ramping stimuli also indicated that the functional deficit was localized to the ON pathway. Analysis of non-human primate retinal responses after drug application demonstrated a complexity to ON / OFF -pathway contributions to ramping ON / OFF ERG responses not previously anticipated. These results support the hypothesis that nyctalopin acts principally or exclusively within the ON pathway at the level of depolarizing bipolar cells, and thus human CSNB1- NYX subjects provide an opportunity to probe the primate visual system for consequences of ON -pathway deficits. Address for reprint requests and other correspondence: Correspondence : Paul Sieving, MD, Ph.D., National Eye Institute, Bldg 31 Room 6A03,31 Center Drive, MSC 2510, Bethesda, MD 20892-2110, Phone: 301-496-2234, Fax: 301-496-9970, Email: paulsieving{at}nei.nih.gov |
Author | Bush, Ronald A Sieving, Paul A Khan, Naheed W Hiriyanna, Kelaginamane T Jamison, Jeff A Kondo, Mineo |
Author_xml | – sequence: 1 fullname: Khan, Naheed W – sequence: 2 fullname: Kondo, Mineo – sequence: 3 fullname: Hiriyanna, Kelaginamane T – sequence: 4 fullname: Jamison, Jeff A – sequence: 5 fullname: Bush, Ronald A – sequence: 6 fullname: Sieving, Paul A |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/15331616$$D View this record in MEDLINE/PubMed |
BookMark | eNptkUtT2zAUhTUMTAnQJduOVt056OFndyFTQmcgMAQGWGlk-SZWasvGkkv9Q_i_KCQdNl1dzdWnc67OPUL7pjGA0CklY0ojdrY2Y0J4HI0ZIeEeGvkeC2iUpftoRIg_c5Ikh-jI2jUhJIkI-4IOacQ5jWk8Qm-3na6lA3wHThtZ4YVe-aLNCt9KV77Kwf7Ai75tO7B2072ZB7sLPFFO_9FuwNrg68b8hgE_alfiWdU7-SE68VLNqgeLr3WtlcWXfS0Nni7m5zSYPz_hGRjvq_Bcr0qHz71vYbzRCTpYysrC1109Rg8XP--nl8HVzezXdHIVKJ7FLkiyJYsjSkGFKoWUAWGpDItUMZ5EXEpJEpXkeVKkwKM8j8NQFlnGwpRLXgCR_Bh93-q2XfPix3Si1lZBVUkDTW8F9TI-NerBYAuqrrG2g6VoN7l1g6BEbPYg1kZ87EFs9uD5bzvhPq-h-KR3wXuAbYHS__xVdyDacrC68XEN4qKvqnv467xoxgUVYUpFWyw_x_3fIz_AP5i_A13Zpko |
CitedBy_id | crossref_primary_10_1007_s10633_018_9645_y crossref_primary_10_1080_13816810_2019_1698617 crossref_primary_10_5402_2012_346297 crossref_primary_10_1016_j_neuron_2006_03_033 crossref_primary_10_1007_s10633_014_9455_9 crossref_primary_10_1016_j_preteyeres_2007_07_003 crossref_primary_10_1113_jphysiol_2005_088468 crossref_primary_10_1007_s10633_014_9452_z crossref_primary_10_1016_j_visres_2007_04_020 crossref_primary_10_1371_journal_pone_0019911 crossref_primary_10_7717_peerj_6277 crossref_primary_10_3390_ijms22147293 crossref_primary_10_1016_j_exer_2008_03_008 crossref_primary_10_1152_jn_00040_2016 crossref_primary_10_3109_13816810_2013_865762 crossref_primary_10_1002_cne_22029 crossref_primary_10_1007_s10633_019_09714_6 crossref_primary_10_1167_tvst_9_11_14 crossref_primary_10_1016_j_visres_2010_08_028 crossref_primary_10_1159_000520895 crossref_primary_10_1167_tvst_10_6_7 crossref_primary_10_1007_s10633_007_9101_x crossref_primary_10_1073_pnas_0501233102 crossref_primary_10_3390_ijms22084030 crossref_primary_10_1016_j_exer_2012_02_009 crossref_primary_10_1017_S0952523810000295 crossref_primary_10_1007_s10633_012_9352_z crossref_primary_10_1016_j_visres_2006_06_011 crossref_primary_10_21516_2072_0076_2019_12_3_77_84 crossref_primary_10_3109_13816810_2012_743570 crossref_primary_10_1016_j_xops_2021_100026 crossref_primary_10_3109_02713683_2016_1141963 crossref_primary_10_1016_j_visres_2007_11_010 crossref_primary_10_1038_s41598_023_38192_9 crossref_primary_10_1017_S0952523811000356 crossref_primary_10_1093_hmg_ddi194 crossref_primary_10_1016_S0246_0343_07_44448_3 crossref_primary_10_1007_s10633_011_9293_y crossref_primary_10_1007_s10633_019_09729_z crossref_primary_10_1007_s00335_005_0018_y crossref_primary_10_1111_vop_12759 crossref_primary_10_1007_s10633_012_9323_4 crossref_primary_10_1016_j_visres_2005_05_026 crossref_primary_10_1017_S0952523805225129 crossref_primary_10_1007_s10633_005_3742_4 crossref_primary_10_1152_jn_00608_2007 crossref_primary_10_1007_s10038_006_0406_5 |
Cites_doi | 10.1098/rspb.1966.0086 10.1523/JNEUROSCI.06-04-00907.1986 10.1016/S0042-6989(96)00212-X 10.1523/JNEUROSCI.12-04-01233.1992 10.1023/A:1020505104334 10.1136/bjo.87.11.1413 10.1002/(SICI)1098-1004(200001)15:1<7::AID-HUMU4>3.0.CO;2-N 10.1016/S0042-6989(00)00119-X 10.1073/pnas.96.24.14130 10.1016/0002-9394(74)90021-X 10.1016/0042-6989(84)90016-6 10.1152/jn.00489.2001 10.1017/S0952523800002431 10.1017/S0952523800009408 10.1523/JNEUROSCI.06-12-03505.1986 10.1167/iovs.02-0115 10.1016/0042-6989(95)98715-L 10.1017/S0952523801181149 10.1152/jn.1995.73.6.2459 10.1016/0042-6989(93)90023-P 10.1126/science.7754386 10.1002/(SICI)1098-1004(1998)11:1<1::AID-HUMU1>3.0.CO;2-O 10.1126/science.6255566 10.1085/jgp.93.1.101 10.1152/jn.1992.67.6.1633 10.1152/jn.1994.72.1.96 10.1113/jphysiol.1992.sp018948 10.1023/A:1002016531591 10.1097/00006324-199202000-00003 10.1073/pnas.92.23.10658 10.1016/S0006-3495(72)86145-9 10.1523/JNEUROSCI.23-30-09881.2003 10.1016/0042-6989(95)00006-L 10.1086/301781 10.1001/archopht.1986.01050190071042 10.1038/81627 10.1167/iovs.02-0989 10.1523/JNEUROSCI.20-11-03956.2000 10.1136/bjo.80.7.637 10.1038/81619 10.1017/S0952523800009986 10.1007/BF02583287 10.1038/294592a0 10.1016/0042-6989(89)90134-X 10.1017/S0952523803203084 10.1016/S0896-6273(00)80560-7 10.1016/S0945-053X(98)90121-4 10.1023/A:1001784614333 10.1152/physrev.1991.71.2.447 10.1097/00006324-199202000-00002 10.1111/j.1460-9568.1992.tb00901.x 10.1038/303537a0 10.1002/cne.10784 10.1002/(SICI)1096-9861(19970929)386:3<443::AID-CNE8>3.0.CO;2-1 10.1152/jn.1986.56.4.1049 10.1364/JOSAA.13.000557 10.1016/0042-6989(93)90122-D 10.1038/314096a0 10.1016/S0002-9394(14)77917-6 10.1007/978-1-4615-5933-7_5 10.1038/308184a0 10.1017/S0952523803203059 10.1002/cne.901720106 10.1017/S0952523801181113 10.1523/JNEUROSCI.06-02-00331.1986 10.1113/jphysiol.1984.sp015518 10.1017/S0952523800009962 10.1016/S0042-6989(97)00035-7 10.1136/jmg.33.10.869 10.1167/iovs.03-0251 10.1016/0042-6989(86)90019-2 10.1007/s00417-002-0562-z 10.1073/pnas.86.5.1726 10.1111/j.1460-9568.1991.tb00043.x 10.1038/940 10.1017/S0952523803202091 10.1167/iovs.02-0501 10.1016/0042-6989(91)90068-G 10.1038/sj.ejhg.5200332 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7TK |
DOI | 10.1152/jn.00365.2004 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Neurosciences Abstracts |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Neurosciences Abstracts |
DatabaseTitleList | CrossRef MEDLINE Neurosciences Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology |
EISSN | 1522-1598 |
EndPage | 492 |
ExternalDocumentID | 10_1152_jn_00365_2004 15331616 jn_93_1_481 |
Genre | Research Support, U.S. Gov't, P.H.S Comparative Study Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: NEI NIH HHS grantid: EY-07003 – fundername: NEI NIH HHS grantid: R01-EY-06094 |
GroupedDBID | - 0VX 1Z7 2WC 39C 3O- 41 53G 55 5GY 5VS AALRV ABFLS ABIVO ABPTK ABUFD ABZEH ACGFS ACNCT ADACO ADBBV ADBIT ADKLL AENEX AETEA AFFNX ALMA_UNASSIGNED_HOLDINGS BAWUL C1A CS3 DIK DL DU5 DZ E3Z EBS EJD F5P FH7 FRP GJ GX1 H13 H~9 KQ8 L7B MVM NEJ O0- OHT OK1 P2P RAP RHF RHI RPL SJN UHB UPT UQL WH7 WOQ WOW X X7M ZA5 ZY4 --- -DZ -~X .55 .GJ 18M 1CY 29L 4.4 41~ 476 8M5 ABCQX ABJNI ABKWE ABTAH ACGFO ADFNX ADIYS AFOSN AI. AIZAD BKKCC BTFSW CGR CUY CVF ECM EIF EMOBN ITBOX NPM RPRKH TR2 VH1 W8F XJT XOL XSW YBH YQT YSK ZGI ZXP AAYXX CITATION 7TK |
ID | FETCH-LOGICAL-c396t-79f26511ec4c8e82e028a4d8c23753aaa07c7bb7d8e35bb644ad992483a3de0a3 |
ISSN | 0022-3077 |
IngestDate | Thu Aug 15 22:49:10 EDT 2024 Thu Sep 26 19:24:14 EDT 2024 Sat Sep 28 07:40:24 EDT 2024 Mon May 06 12:25:37 EDT 2019 Tue Jan 05 17:54:13 EST 2021 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c396t-79f26511ec4c8e82e028a4d8c23753aaa07c7bb7d8e35bb644ad992483a3de0a3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
PMID | 15331616 |
PQID | 17530001 |
PQPubID | 23462 |
PageCount | 12 |
ParticipantIDs | crossref_primary_10_1152_jn_00365_2004 highwire_physiology_jn_93_1_481 pubmed_primary_15331616 proquest_miscellaneous_17530001 |
PublicationCentury | 2000 |
PublicationDate | 20050101 2005-Jan 2005-01-00 |
PublicationDateYYYYMMDD | 2005-01-01 |
PublicationDate_xml | – month: 01 year: 2005 text: 20050101 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Journal of neurophysiology |
PublicationTitleAlternate | J Neurophysiol |
PublicationYear | 2005 |
Publisher | Am Phys Soc |
Publisher_xml | – name: Am Phys Soc |
References | R21 R20 R23 R22 R25 R24 R27 R20A R26 R29 R28 R1 R2 R3 R4 R5 R6 R7 R8 R9 R55A R30 R32 R31 R34 R33 R36 R35 R38 R37 R39 R41 R40 R43 R42 R45 R44 R47 R46 R49 R48 R50 R52 R51 R54 R53 R56 R55 R58 R57 R21A R59 R24A R61 R60 R63 R62 R65 R64 R67 R66 R69 R68 R70 R72 R71 R74 R73 R76 R75 R51B R78 R77 R51A R79 R75A R81 R80 R83 R82 R85 R84 R87 R86 R89 R88 R90 R92 R91 R94 R93 R10 R12 R11 R14 R13 R16 R65A R15 R53A R18 R17 R19 |
References_xml | – ident: R22 doi: 10.1098/rspb.1966.0086 – ident: R51B doi: 10.1523/JNEUROSCI.06-04-00907.1986 – ident: R64 doi: 10.1016/S0042-6989(96)00212-X – ident: R45 doi: 10.1523/JNEUROSCI.12-04-01233.1992 – ident: R85 doi: 10.1023/A:1020505104334 – ident: R7 doi: 10.1136/bjo.87.11.1413 – ident: R23 doi: 10.1002/(SICI)1098-1004(200001)15:1<7::AID-HUMU4>3.0.CO;2-N – ident: R6 doi: 10.1016/S0042-6989(00)00119-X – ident: R29 doi: 10.1073/pnas.96.24.14130 – ident: R32 doi: 10.1016/0002-9394(74)90021-X – ident: R41 doi: 10.1016/0042-6989(84)90016-6 – ident: R48 doi: 10.1152/jn.00489.2001 – ident: R68 – ident: R47 – ident: R71 doi: 10.1017/S0952523800002431 – ident: R63 doi: 10.1017/S0952523800009408 – ident: R75A doi: 10.1523/JNEUROSCI.06-12-03505.1986 – ident: R59 doi: 10.1167/iovs.02-0115 – ident: R82 doi: 10.1016/0042-6989(95)98715-L – ident: R91 – ident: R9 doi: 10.1017/S0952523801181149 – ident: R36 – ident: R89 doi: 10.1152/jn.1995.73.6.2459 – ident: R46 doi: 10.1016/0042-6989(93)90023-P – ident: R65A doi: 10.1126/science.7754386 – ident: R8 doi: 10.1002/(SICI)1098-1004(1998)11:1<1::AID-HUMU1>3.0.CO;2-O – ident: R72 doi: 10.1126/science.6255566 – ident: R53A – ident: R78 doi: 10.1085/jgp.93.1.101 – ident: R80 doi: 10.1152/jn.1992.67.6.1633 – ident: R88 doi: 10.1152/jn.1994.72.1.96 – ident: R30 doi: 10.1113/jphysiol.1992.sp018948 – ident: R51 doi: 10.1023/A:1002016531591 – ident: R56 doi: 10.1097/00006324-199202000-00003 – ident: R21A doi: 10.1073/pnas.92.23.10658 – ident: R14 – ident: R58 doi: 10.1016/S0006-3495(72)86145-9 – ident: R51A – ident: R40 doi: 10.1523/JNEUROSCI.23-30-09881.2003 – ident: R20 – ident: R83 doi: 10.1016/0042-6989(95)00006-L – ident: R17 doi: 10.1086/301781 – ident: R53 doi: 10.1001/archopht.1986.01050190071042 – ident: R61 doi: 10.1038/81627 – ident: R3 doi: 10.1167/iovs.02-0989 – ident: R24A doi: 10.1523/JNEUROSCI.20-11-03956.2000 – ident: R38 doi: 10.1136/bjo.80.7.637 – ident: R12 doi: 10.1038/81619 – ident: R75 doi: 10.1017/S0952523800009986 – ident: R93 – ident: R62 doi: 10.1007/BF02583287 – ident: R4 – ident: R34 – ident: R67 doi: 10.1038/294592a0 – ident: R84 – ident: R15 doi: 10.1016/0042-6989(89)90134-X – ident: R69 – ident: R87 doi: 10.1017/S0952523803203084 – ident: R26 – ident: R76 doi: 10.1016/S0896-6273(00)80560-7 – ident: R5 – ident: R33 doi: 10.1016/S0945-053X(98)90121-4 – ident: R49 doi: 10.1023/A:1001784614333 – ident: R86 doi: 10.1152/physrev.1991.71.2.447 – ident: R18 doi: 10.1097/00006324-199202000-00002 – ident: R20A doi: 10.1111/j.1460-9568.1992.tb00901.x – ident: R73 doi: 10.1038/303537a0 – ident: R25 doi: 10.1002/cne.10784 – ident: R42 doi: 10.1002/(SICI)1096-9861(19970929)386:3<443::AID-CNE8>3.0.CO;2-1 – ident: R70 doi: 10.1152/jn.1986.56.4.1049 – ident: R19 doi: 10.1364/JOSAA.13.000557 – ident: R28 doi: 10.1016/0042-6989(93)90122-D – ident: R74 doi: 10.1038/314096a0 – ident: R81 – ident: R43 – ident: R2 – ident: R31 doi: 10.1016/S0002-9394(14)77917-6 – ident: R52 doi: 10.1007/978-1-4615-5933-7_5 – ident: R57 – ident: R50 doi: 10.1038/308184a0 – ident: R44 – ident: R10 doi: 10.1017/S0952523803203059 – ident: R55A doi: 10.1002/cne.901720106 – ident: R60 doi: 10.1017/S0952523801181113 – ident: R77 – ident: R21 doi: 10.1523/JNEUROSCI.06-02-00331.1986 – ident: R11 doi: 10.1113/jphysiol.1984.sp015518 – ident: R90 doi: 10.1017/S0952523800009962 – ident: R92 – ident: R35 – ident: R39 doi: 10.1016/S0042-6989(97)00035-7 – ident: R13 doi: 10.1136/jmg.33.10.869 – ident: R94 doi: 10.1167/iovs.03-0251 – ident: R24 doi: 10.1016/0042-6989(86)90019-2 – ident: R66 – ident: R37 doi: 10.1007/s00417-002-0562-z – ident: R55 doi: 10.1073/pnas.86.5.1726 – ident: R16 doi: 10.1111/j.1460-9568.1991.tb00043.x – ident: R79 doi: 10.1038/940 – ident: R1 doi: 10.1017/S0952523803202091 – ident: R27 doi: 10.1167/iovs.02-0501 – ident: R54 doi: 10.1016/0042-6989(91)90068-G – ident: R65 doi: 10.1038/sj.ejhg.5200332 |
SSID | ssj0007502 |
Score | 2.0643842 |
Snippet | 1 Department of Ophthalmology and Visual Sciences, W. K. Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan; and 2 National Institute of Deafness... Retinal on-pathway dysfunction is implicated in human complete-type congenital stationary night blindness (CSNB1), a Mendelian genetic condition that results... Retinal ON-pathway dysfunction is implicated in human complete-type congenital stationary night blindness (CSNB1), a Mendelian genetic condition that results... |
SourceID | proquest crossref pubmed highwire |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 481 |
SubjectTerms | Adolescent Adult Aminobutyrates - pharmacology Animals DNA Mutational Analysis - methods Dose-Response Relationship, Radiation Drug Interactions Electroretinography - methods Excitatory Amino Acid Agonists - pharmacology Excitatory Amino Acid Antagonists - pharmacology Female Glutamic Acid - analogs & derivatives Glutamic Acid - pharmacology Humans Macaca mulatta Male Middle Aged Mutation Night Blindness - genetics Night Blindness - physiopathology Photic Stimulation Pipecolic Acids - pharmacology Primates Proteoglycans - genetics Retina - drug effects Retina - physiopathology Visual Pathways - drug effects Visual Pathways - physiopathology |
Title | Primate Retinal Signaling Pathways: Suppressing ON-Pathway Activity in Monkey With Glutamate Analogues Mimics Human CSNB1-NYX Genetic Night Blindness |
URI | http://jn.physiology.org/cgi/content/abstract/93/1/481 https://www.ncbi.nlm.nih.gov/pubmed/15331616 https://search.proquest.com/docview/17530001 |
Volume | 93 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6FcuGCgPIIzzmgXiyHxF6_uKUVULVqFNRUhJO1Xq8bV2RTtY5Q-CP8MP4Qsw_bCQ1S4WJF67W9zny78_DsN4S8LXxesJAHbo4OrYsa33NZkA_ciLKiyIuEZnr72MkoPDyjR9Ng2un8WstaWlZZj__Yuq_kf6SKbShXtUv2HyTb3BQb8DfKF48oYTzeSsZjRRVRqcoLlS5udVqeK7sanf8xGnbf2Urnu6nCnTrbVeU3S8e155wht5UjSqmmNs5mXCOqmfMJh8z0fRVjiQrtXDsn5VzROZuQ_8HpaH_gOqOvU81arShfR8rHd_bx2bmsczpumryaPFPHUjaC-cczE4UdsRnqUudLrzmhao2Y5H4pFm2U_KpcMWk3s4lvqs4Sjhet5Ulz5RGbl3Yvmf6EPexthDeCtfDG2naDvq31IuwqjW1oh8Xry7gptLgBV7MmU1MTxqp3akrv3dQcgWKivZA9xdAT6MBBqyLrtIA_NGeTz6g9qcBLL2SqL1fFPekdcteLkkBFBI4_txT2aKK1FPb4XjXxa-C923j6pqFUk1f_3RHSBtHkAblvxQpDA8uHpCPkI7KLkKkW8xXswbiR8y75aZEKFqnQIBVqpL6HNZzCQkKNU6hxCqUEg1NQOIUGp9DgFAxOQeMUDE4BcQoWp6BxCg1OH5Ozjx8mB4euLQnicj8JKzdKCi9EH0FwymMRewLNY0bzmHs--t2MsX7EoyyL8lj4QZahsc_yJPFo7DM_F33mPyE7ciHFMwKh7xfY6PUz6lNcsrKcZjwRAx5wjmZv1iV79f-fXhrml3SrnLvEqaWTtlMoVSGkCcIEOyd-OkgRhullXnTJm2298Y51L-xRizjFuaI-4OEUWiyvU8Wqq5yyLnlqJN8ODL029N3C57cd9Atyr51tL8lOdbUUr9C8rrLXGq6_AWse07g |
link.rule.ids | 315,786,790,27957,27958 |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Primate+Retinal+Signaling+Pathways%3A+Suppressing+on+-Pathway+Activity+in+Monkey+With+Glutamate+Analogues+Mimics+Human+CSNB1-+NYX+Genetic+Night+Blindness&rft.jtitle=Journal+of+neurophysiology&rft.au=Khan%2C+Naheed+W.&rft.au=Kondo%2C+Mineo&rft.au=Hiriyanna%2C+Kelaginamane+T.&rft.au=Jamison%2C+Jeff+A.&rft.date=2005-01-01&rft.issn=0022-3077&rft.eissn=1522-1598&rft.volume=93&rft.issue=1&rft.spage=481&rft.epage=492&rft_id=info:doi/10.1152%2Fjn.00365.2004&rft.externalDBID=n%2Fa&rft.externalDocID=10_1152_jn_00365_2004 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-3077&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-3077&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-3077&client=summon |